Skip to main content

Assessing Prevention for Positives: Cost-Utility Assessment of Behavioral Interventions for Reducing HIV Transmission

  • Chapter
  • First Online:
Operations Research and Health Care Policy

Part of the book series: International Series in Operations Research & Management Science ((ISOR,volume 190))

  • 2280 Accesses

Abstract

Typical studies of HIV behavioral interventions measure relative risk reduction for HIV transmission. Here, we also consider the health benefits of such interventions on secondary transmission. In addition, a sensitivity analysis explores the potential additional benefits that may accrue if partners of those in the intervention group also adopt the risk reducing behavior. To do this, we developed an ordinary differential equation (ODE) model to analyze the cost and utility (measured in quality-adjusted life years, or QALYs) of a published behavioral HIV intervention that aims to reduce the risk of transmission from HIV-infected persons to their sexual partners. The ODE model maps measurements of behavioral risk reduction parameters, estimated from sampling, into costs and QALYs. Monte Carlo sampling was used to perform a probabilistic sensitivity analysis to quantify uncertainty in costs and QALYs due to parameter estimation error for the behavioral HIV intervention. The results suggest that the behavioral intervention is most likely to be cost-saving or, at least, cost-effective. The analysis highlights the step of converting uncertainty about estimates of mean values of parameters that are commonly reported in the literature to uncertainty about the costs and health benefits of an intervention. It also shows the potential importance of considering secondary transmission of HIV and the partial adoption of behavior change by partners of the individuals who undergo the intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. CDC (2010) Projecting possible future courses of the HIV epidemic in the United States. http://www.cdc.gov/hiv/resources/factsheets/us-epi-future-courses.htm. Accessed 13 Nov 2011

  2. Janssen R, Onorato I, Valdiserri R et al. (2003) Advancing HIV prevention: new strategies for a changing epidemic—United States. Morb Mortal Wkly Rep 52:329–332

    Google Scholar 

  3. Johnson B, Carey M, Chaudoir S et al. (2006) Sexual risk reduction for persons living with HIV: research synthesis of randomized controlled trials, 1993 to 2004. J Acquir Immune Defic Syndr 41:642–650

    Article  Google Scholar 

  4. Herbst J, Sherba R, Crepaz N et al. (2005) A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr 39:228–241

    Google Scholar 

  5. Lyles C, Kay L, Crepaz N et al. (2007) Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health 97:133–143

    Article  Google Scholar 

  6. Kalichman S, Rompa D, Cage M et al. (2001) Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med 21:84–92

    Article  Google Scholar 

  7. Soorapanth S, Chick SE (2010) Cost-utility analysis of behavioral interventions for HIV-infected persons to reduce HIV transmission in the USA. In: Johansson B, Jain S, Montoya-Torres J, Hugan J, Yücesan E (eds) Proc Winter Sim Conf. IEEE, Piscataway, NJ, pp 2433–2443

    Google Scholar 

  8. Ekstrand ML, Coates TJ (1990) Maintenance of safer sexual behavior and predictors of risky sex: the San Francisco Men’s Health Study. Am J Public Health 80:973–977

    Article  Google Scholar 

  9. Stall R, Ekstrand ML, Pollack L et al. (1990) Relapse from safer sex: the next challenge for AIDS prevention efforts. J Acquir Immune Defic Syndr 3:1181–1187

    Google Scholar 

  10. Adib SM, Joseph JG, Ostrow DG et al. (1991) Relapse in sexual behavior among homosexual men: a 2-year follow-up from the Chicago MACS/CCS. AIDS 5:757–760

    Article  Google Scholar 

  11. Brandeau ML, Owens K (1994) When women return to risk: costs and benefits of HIV screening in the presence of relapse. In: Kaplan EH, Brandeau ML (eds) Modeling the AIDS epidemic: planning, policy and prediction. Raven, New York

    Google Scholar 

  12. Diekmann O, Heesterbeek JAP (2000) Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Wiley, Chichester, England

    Google Scholar 

  13. Brennan A, Chick SE, Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies. Health Econ 15:1295–1310

    Article  Google Scholar 

  14. US Bureau of Labor Statistics (2009) Consumer price index databases. http://www.bls.gov/cpi/cpi_dr.htm. Accessed 6 Apr 2010

  15. CDC (2001) Revised guidelines for HIV counseling, testing, and referral. Morb Mortal Wkly Rep 50(RR19):1–58. www.cdc.gov/mmwr/preview/mmwrhtml/rr5019a1.htm. Accessed 15 Nov 2011

  16. European study group on heterosexual transmission of HIV (1992) Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 304(6830):809–813. doi: 10.1136/bmj.304.6830.809. PMC 1881672. PMID 1392708

    Article  Google Scholar 

  17. Varghese B, Maher JE, Peterman TA et al. (2002) Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 29(1):38–43. doi: 10.1097/00007435-200201000-00007. PMID 11773877

    Article  Google Scholar 

  18. Boily MC, Baggaley RF, Wang L et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2):118–129. doi: 10.1016/S1473-3099(09)70021-0. PMID 19179227

    Article  Google Scholar 

  19. Sanders G, Bayoumi A, Sundaram V et al. (2005) Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352:570–585

    Article  Google Scholar 

  20. National Center for Health Statistics (2009) Health, United States, 2008, With Cartbook, Hyattville, MD. http://www.cdc.gov/nchs/data/hus/hus08.pdf#026. Accessed 16 Sept 2009

  21. Cohen D, Wu SY, Farley T (2004) Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr 37:1404–1414

    Article  Google Scholar 

  22. Pinkerton S, Holtgrave D, DiFranceisco W et al. (2000) Cost-threshold analyses of the National AIDS demonstration research HIV prevention interventions. AIDS 14:1257–1268

    Article  Google Scholar 

  23. Schackman B, Gebo K, Walensky R et al. (2006) The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 44:990–997

    Article  Google Scholar 

  24. Kelly J, Kalichman S (2002) Behavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directions. J Consult Clin Psychol 70:626–639

    Article  Google Scholar 

  25. Crepaz N, Lyles C, Wolitski R (2006) Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 20:143–157

    Article  Google Scholar 

  26. Wolitsky R, Gomez C, Parson J et al. (2005) Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS 19:S99–S109

    Article  Google Scholar 

  27. Richardson J, Milam J, McCutchan A (2004) Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS 18:1179–1186

    Article  Google Scholar 

  28. Patterson T, Shaw W, Semple S (2003) Reducing the sexual risk behaviors of HIV + individuals: outcome of a randomized controlled trial. Ann Behav Med 25:137–145

    Article  Google Scholar 

  29. Rotheram-Borus M, Swendeman D, Comulada W et al. (2004) Prevention for substance-using HIV-positive young people telephone and in-person delivery. J Acquir Immune Defic Syndr 37(Suppl 2):S68–S77

    Article  Google Scholar 

  30. US Bureau of Labor Statistics (2009) National occupational employment and wage estimates United States. http://www.bls.gov/oes/2009/may/oes_nat.htm. Accessed 25 Oct 2011

  31. Garland W, Wohl A, Valencia R et al. (2007) The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California. AIDS Care 19:159–167

    Article  Google Scholar 

  32. Tuli K, Sansom S, Purcell D et al. (2005) Economic evaluation of an HIV prevention intervention for seropositive injection drug users. J Public Health Manag Pract 11:508–515

    Google Scholar 

  33. Claxton K, Sculpher M, McCabe C et al. (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 14(4):339–347

    Article  Google Scholar 

  34. Owens DK (1998) Interpretation of cost-effectiveness analyses. J Gen Intern Med 13(10):716–717

    Article  Google Scholar 

  35. Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 8(2):165–178

    Article  Google Scholar 

  36. Macroeconomics and health (2001) Investing in health for economic development. Report of the Commission on Macroeconomics and Health (CMH) of the World Health Organization, S.J. D, Editor, World Health Organization, Geneva

    Google Scholar 

  37. Ng SH, Chick SE (2006) Reducing parameter uncertainty for stochastic systems. ACM TOMACS 15(1):26–51

    Article  Google Scholar 

  38. Koopman J, Jacquez J, Welch G et al. (1997) The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 14:249–258

    Article  Google Scholar 

  39. Vimalanand P, Farnham P, Hutchinson A et al. (2011) Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis. PLoS One 6(5):e19936. doi:10.1371/journal.pone.0019936

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sada Soorapanth .

Editor information

Editors and Affiliations

Appendix

Appendix

The ODE for S(t) in (8.1) and the discounted cost and QALY equations in (8.4) and (8.5) drive the analysis. The term S(t) is readily solvable in closed form when the time-varying parameters are assumed to be piecewise constant on a sequence of intervals in (8.1). For the behavioral interventions that we modeled, we assumed that these parameters were indeed piecewise constant on intervals. In particular, the functional form of (8.1) for the studies that we analyzed is

$$ \mathrm{ d}S(t)/\mathrm{ d}t={a_i}+{b_i}S(t),\ \mathrm{ for}\ t\in [{\tau_i},\;{\tau_{i+1 }}) $$

where τ 0 = 0, τ 1 is the time of initiation of the behavioral intervention, τ 2 − τ 1 is the duration of the intervention, τ 3 is the time through which infections are counted for the purpose of the endpoint of the study, and τ 4 = ∞ allows S(t) to be defined for all t ≥ 0. We assumed that τ i  ≤ τ i + 1 for i = 0, 1, 2, 3, meaning that a i  = λ S (t) and b i = −[μ S (t) + γ(t) + β(t) + α S (t)] were constant for t in [τ i , τ i+1). The constants may differ depending on the intervention for each i.

The solution is straightforward by a quick change of variables for each interval [τ i , τ i+1). If we set T(t) = a i  + b i S(t), we obtain dT(t)/dt = b i T(t), which has solution T(t) = c i exp[b i t] for some constant c i . Solving for S(t) we get

$$ S(t)={c_i}\exp [{b_i}t]/{b_i}-{a_i}/{b_i},\ \mathrm{ for}\ t\in [{\tau_i},\;{\tau_{i+1 }}). $$

The value of c i is determined by the preceding equation, which implies c i  = b i s i  + a i , and the initial condition S(τ 0) = s 0. We evaluate this first for i = 0 to obtain

$$ S(t)={s_0}\exp [{b_0}t]/{b_0}-{a_0}(\exp [{b_0}t]-1)/{b_0},\ \mathrm{ for}\ t\in [{\tau_0},\;{\tau_1}). $$

This determines s i+1 = S(τ i+1) = s i exp[b i (τ i+1 − τ i )] − a i /b i (exp[b i (τ i+1 − τ i )] − 1), which we sequentially evaluate for i = 0, 1, 2, 3. Thus, a closed-form expression for S(t) is found by iterating over each time interval, with the parameters of the intervention set to constants in each interval. A similar analysis can be used obtain an iterated closed-form solution for the number of individuals infected up to a given time t.

This analysis was used to debug the spreadsheet code, which implements a forward Euler finite difference approximation to the ODE. The spreadsheet code additionally can be modified to have more flexibility than allowed by the piecewise linear assumption for the parameters.

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Soorapanth, S., Chick, S.E. (2013). Assessing Prevention for Positives: Cost-Utility Assessment of Behavioral Interventions for Reducing HIV Transmission. In: Zaric, G. (eds) Operations Research and Health Care Policy. International Series in Operations Research & Management Science, vol 190. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6507-2_8

Download citation

Publish with us

Policies and ethics